The Future of Cancer Treatment
Immuno-oncology is a new and rapidly growing field of cancer treatment that is based on understanding the body’s immune response to cancer. This knowledge has produced immensely efficacious mono-clonal antibody cancer therapies, such as nivolumab (Opdivo) and ipilimumab (Yervoy).
GigaGen has an internal discovery pipeline against 15 immuno-oncology targets including PD-1.
GigaGen is interested in significant, multi-target discovery collaborations and licensing opportunities.
Please contact us for more information.